129 related articles for article (PubMed ID: 12679187)
1. Role for thromboxane A2 from glomerular thrombi in nephropathy with type 2 diabetic rats.
Okumura M; Imanishi M; Okamura M; Hosoi M; Okada N; Konishi Y; Morikawa T; Miura K; Nakatani T; Fujii S
Life Sci; 2003 May; 72(24):2695-705. PubMed ID: 12679187
[TBL] [Abstract][Full Text] [Related]
2. Effect of acute thromboxane A2 inhibition on the renal hemodynamics in a spontaneously non-insulin-dependent diabetic rat, Otsuka Long-Evans Tokushima Fatty rat.
Uriu K; Kaizu K; Qie YL; Kai K; Eto S
J Diabetes Complications; 1999; 13(4):182-6. PubMed ID: 10616856
[TBL] [Abstract][Full Text] [Related]
3. Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy.
Hora K; Oguchi H; Furukawa T; Hora K; Tokunaga S
Nephron; 1990; 56(3):297-305. PubMed ID: 2077412
[TBL] [Abstract][Full Text] [Related]
4. Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes.
Okumura M; Imanishi M; Yamashita T; Yamamura Y; Kim S; Iwao H; Tanaka S; Fujii S
Life Sci; 2000; 66(5):371-7. PubMed ID: 10670825
[TBL] [Abstract][Full Text] [Related]
5. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane A2 and the development of hypertension in spontaneously hypertensive rats.
Stier CT; Itskovitz HD
Eur J Pharmacol; 1988 Jan; 146(1):129-35. PubMed ID: 3350054
[TBL] [Abstract][Full Text] [Related]
7. Effects of thromboxane synthetase inhibitor (OKY-046) on urinary prostaglandin excretion and renal function in streptozotocin-induced diabetic rat.
Tajiri Y; Umeda F; Inoguchi T; Nawata H
J Diabetes Complications; 1994; 8(2):126-32. PubMed ID: 8061349
[TBL] [Abstract][Full Text] [Related]
8. Different effects of castration and estrogen administration on glomerular injury in spontaneously hyperglycemic Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Tomiyoshi Y; Sakemi T; Aoki S; Miyazono M
Nephron; 2002 Dec; 92(4):860-7. PubMed ID: 12399633
[TBL] [Abstract][Full Text] [Related]
9. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
Koike T; Tomoda F; Kinuno H; Inoue H; Takata M
Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646
[TBL] [Abstract][Full Text] [Related]
10. Reduction of urinary albumin excretion by thromboxane synthetase inhibitor, OKY-046, through modulating renal prostaglandins in patients with diabetic nephropathy.
Tajiri Y; Inoguchi T; Umeda F; Nawata H
Diabetes Res Clin Pract; 1990; 10(3):231-9. PubMed ID: 2073870
[TBL] [Abstract][Full Text] [Related]
11. Decrease in tetrahydrobiopterin as a possible cause of nephropathy in type II diabetic rats.
Okumura M; Masada M; Yoshida Y; Shintaku H; Hosoi M; Okada N; Konishi Y; Morikawa T; Miura K; Imanishi M
Kidney Int; 2006 Aug; 70(3):471-6. PubMed ID: 16775605
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandins and diabetic nephropathy.
Umeda F; Kuroki T; Nawata H
J Diabetes Complications; 1995; 9(4):334-6. PubMed ID: 8573760
[TBL] [Abstract][Full Text] [Related]
13. Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats.
Kamijo H; Higuchi M; Hora K
Nephron Physiol; 2006; 104(1):p12-22. PubMed ID: 16691035
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic effects of thromboxane A2 inhibition on the renal hemodynamics in streptozotocin-induced diabetic rats.
Uriu K; Kaizu K; Hashimoto O; Komine N; Etoh S
Kidney Int; 1994 Mar; 45(3):794-802. PubMed ID: 8196281
[TBL] [Abstract][Full Text] [Related]
15. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
16. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.
Hatziantoniou C; Papanikolaou N
Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267
[TBL] [Abstract][Full Text] [Related]
17. Effects of captopril on urinary excretion of albumin and prostaglandins in patients with diabetic nephropathy.
Tajiri Y; Umeda F; Inoguchi T; Kunisaki M; Nawata H; Ninomiya H; Asano T
Diabetes Res; 1990 Mar; 13(3):145-50. PubMed ID: 2091882
[TBL] [Abstract][Full Text] [Related]
18. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
[TBL] [Abstract][Full Text] [Related]
19. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
Okada M; Takemura T; Yanagida H; Yoshioka K
Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
[TBL] [Abstract][Full Text] [Related]
20. Increased renal TXA2 synthesis in diabetes mellitus: simultaneous determination of urinary TXB2 and 2,3-dinor-TXB2.
Katayama S; Inaba M; Maruno Y; Omoto A; Kawazu S; Ishii J; Sawada M
Prostaglandins Leukot Essent Fatty Acids; 1990 Jan; 39(1):47-51. PubMed ID: 2339136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
